APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Nitric Oxide

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Selected research

Market Analysis & Forecast

Global Inhaled Nitric Oxide Market Analysis and Forecast 2026-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchInhaled Nitric Oxide Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Nitric Oxide Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Inhaled Nitric Oxide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Nitric Oxide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Nitric Oxide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

Read the full market overview

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

This report presents an overview of global market for Inhaled Nitric Oxide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Inhaled Nitric Oxide, also provides the sales of main regions and countries. Of the upcoming market potential for Inhaled Nitric Oxide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhaled Nitric Oxide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Inhaled Nitric Oxide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Inhaled Nitric Oxide sales, projected growth trends, production technology, application and end-user industry.

Inhaled Nitric Oxide Segment by Company

Mallinckrodt

Praxair (Linde plc)

Air Liquide

BOC Healthcare (Linde Group)

Inhaled Nitric Oxide Segment by Type

800 ppm

100 ppm

Others

Inhaled Nitric Oxide Segment by Application

Near-term and Pre-term Infants PPHN

Children and Adult ARDS

Other Diseases

Inhaled Nitric Oxide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Inhaled Nitric Oxide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled Nitric Oxide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhaled Nitric Oxide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 800 ppm Major Manufacturers Table 3. 100 ppm Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Inhaled Nitric Oxide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Near-term and Pre-term Infants PPHN Major Manufacturers Table 7. Children and Adult ARDS Major Manufacturers Table 8. Other Diseases Major Manufacturers Table 9. Inhaled Nitric Oxide Industry Trends Table 10. Inhaled Nitric Oxide Industry Drivers Table 11. Inhaled Nitric Oxide Industry Opportunities and Challenges Table 12. Inhaled Nitric Oxide Industry Restraints Table 13. Global Inhaled Nitric Oxide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Inhaled Nitric Oxide Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Inhaled Nitric Oxide Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Inhaled Nitric Oxide Revenue Market Share by Region (2021-2026) Table 17. Global Inhaled Nitric Oxide Revenue Market Share by Region (2027-2032) Table 18. Global Inhaled Nitric Oxide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M L) Table 19. Global Inhaled Nitric Oxide Sales by Region (2021-2026) & (M L) Table 20. Global Inhaled Nitric Oxide Sales by Region (2027-2032) & (M L) Table 21. Global Inhaled Nitric Oxide Sales Market Share by Region (2021-2026) Table 22. Global Inhaled Nitric Oxide Sales Market Share by Region (2027-2032) Table 23. Global Inhaled Nitric Oxide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Inhaled Nitric Oxide Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2021-2026) Table 27. Global Inhaled Nitric Oxide Sales Price (US$/L) of Manufacturers (2021-2026) Table 28. Global Inhaled Nitric Oxide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Inhaled Nitric Oxide Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Inhaled Nitric Oxide Manufacturers, Product Type & Application Table 31. Global Inhaled Nitric Oxide Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Inhaled Nitric Oxide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Inhaled Nitric Oxide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Inhaled Nitric Oxide Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Inhaled Nitric Oxide Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Inhaled Nitric Oxide Revenue Market Share by Type (2021-2026) Table 38. Global Inhaled Nitric Oxide Revenue Market Share by Type (2027-2032) Table 39. Global Inhaled Nitric Oxide Sales by Type 2021 VS 2025 VS 2032 (M L) Table 40. Global Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 41. Global Inhaled Nitric Oxide Sales by Type (2027-2032) & (M L) Table 42. Global Inhaled Nitric Oxide Sales Market Share by Type (2021-2026) Table 43. Global Inhaled Nitric Oxide Sales Market Share by Type (2027-2032) Table 44. Global Inhaled Nitric Oxide Price by Type (2021-2026) & (US$/L) Table 45. Global Inhaled Nitric Oxide Price by Type (2027-2032) & (US$/L) Table 46. Global Inhaled Nitric Oxide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Inhaled Nitric Oxide Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Inhaled Nitric Oxide Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Inhaled Nitric Oxide Revenue Market Share by Application (2021-2026) Table 50. Global Inhaled Nitric Oxide Revenue Market Share by Application (2027-2032) Table 51. Global Inhaled Nitric Oxide Sales by Application 2021 VS 2025 VS 2032 (M L) Table 52. Global Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 53. Global Inhaled Nitric Oxide Sales by Application (2027-2032) & (M L) Table 54. Global Inhaled Nitric Oxide Sales Market Share by Application (2021-2026) Table 55. Global Inhaled Nitric Oxide Sales Market Share by Application (2027-2032) Table 56. Global Inhaled Nitric Oxide Price by Application (2021-2026) & (US$/L) Table 57. Global Inhaled Nitric Oxide Price by Application (2027-2032) & (US$/L) Table 58. Mallinckrodt Company Information Table 59. Mallinckrodt Business Overview Table 60. Mallinckrodt Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 61. Mallinckrodt Inhaled Nitric Oxide Product Portfolio Table 62. Mallinckrodt Recent Development Table 63. Praxair (Linde plc) Company Information Table 64. Praxair (Linde plc) Business Overview Table 65. Praxair (Linde plc) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 66. Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio Table 67. Praxair (Linde plc) Recent Development Table 68. Air Liquide Company Information Table 69. Air Liquide Business Overview Table 70. Air Liquide Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 71. Air Liquide Inhaled Nitric Oxide Product Portfolio Table 72. Air Liquide Recent Development Table 73. BOC Healthcare (Linde Group) Company Information Table 74. BOC Healthcare (Linde Group) Business Overview Table 75. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 76. BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio Table 77. BOC Healthcare (Linde Group) Recent Development Table 78. North America Inhaled Nitric Oxide Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Inhaled Nitric Oxide Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 81. North America Inhaled Nitric Oxide Sales by Type (2027-2032) & (M L) Table 82. North America Inhaled Nitric Oxide Sales Price by Type (2021-2026) & (US$/L) Table 83. North America Inhaled Nitric Oxide Sales Price by Type (2027-2032) & (US$/L) Table 84. North America Inhaled Nitric Oxide Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Inhaled Nitric Oxide Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 87. North America Inhaled Nitric Oxide Sales by Application (2027-2032) & (M L) Table 88. North America Inhaled Nitric Oxide Sales Price by Application (2021-2026) & (US$/L) Table 89. North America Inhaled Nitric Oxide Sales Price by Application (2027-2032) & (US$/L) Table 90. North America Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Inhaled Nitric Oxide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America Inhaled Nitric Oxide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032) & (M L) Table 94. North America Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 95. North America Inhaled Nitric Oxide Sales by Country (2027-2032) & (M L) Table 96. North America Inhaled Nitric Oxide Sales Price by Country (2021-2026) & (US$/L) Table 97. North America Inhaled Nitric Oxide Sales Price by Country (2027-2032) & (US$/L) Table 98. United States Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 99. Canada Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 100. Mexico Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 101. Europe Inhaled Nitric Oxide Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Inhaled Nitric Oxide Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 104. Europe Inhaled Nitric Oxide Sales by Type (2027-2032) & (M L) Table 105. Europe Inhaled Nitric Oxide Sales Price by Type (2021-2026) & (US$/L) Table 106. Europe Inhaled Nitric Oxide Sales Price by Type (2027-2032) & (US$/L) Table 107. Europe Inhaled Nitric Oxide Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Inhaled Nitric Oxide Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 110. Europe Inhaled Nitric Oxide Sales by Application (2027-2032) & (M L) Table 111. Europe Inhaled Nitric Oxide Sales Price by Application (2021-2026) & (US$/L) Table 112. Europe Inhaled Nitric Oxide Sales Price by Application (2027-2032) & (US$/L) Table 113. Europe Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Inhaled Nitric Oxide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe Inhaled Nitric Oxide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032) & (M L) Table 117. Europe Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 118. Europe Inhaled Nitric Oxide Sales by Country (2027-2032) & (M L) Table 119. Europe Inhaled Nitric Oxide Sales Price by Country (2021-2026) & (US$/L) Table 120. Europe Inhaled Nitric Oxide Sales Price by Country (2027-2032) & (US$/L) Table 121. Germany Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 122. France Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 123. U.K. Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 124. Italy Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 125. Russia Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 126. Spain Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 127. Netherlands Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 128. Switzerland Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 129. Sweden Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 130. Poland Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 131. China Inhaled Nitric Oxide Revenue by Type (2021-2026) & (US$ Million) Table 132. China Inhaled Nitric Oxide Revenue by Type (2027-2032) & (US$ Million) Table 133. China Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 134. China Inhaled Nitric Oxide Sales by Type (2027-2032) & (M L) Table 135. China Inhaled Nitric Oxide Sales Price by Type (2021-2026) & (US$/L) Table 136. China Inhaled Nitric Oxide Sales Price by Type (2027-2032) & (US$/L) Table 137. China Inhaled Nitric Oxide Revenue by Application (2021-2026) & (US$ Million) Table 138. China Inhaled Nitric Oxide Revenue by Application (2027-2032) & (US$ Million) Table 139. China Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 140. China Inhaled Nitric Oxide Sales by Application (2027-2032) & (M L) Table 141. China Inhaled Nitric Oxide Sales Price by Application (2021-2026) & (US$/L) Table 142. China Inhaled Nitric Oxide Sales Price by Application (2027-2032) & (US$/L) Table 143. Asia Inhaled Nitric Oxide Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Inhaled Nitric Oxide Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 146. Asia Inhaled Nitric Oxide Sales by Type (2027-2032) & (M L) Table 147. Asia Inhaled Nitric Oxide Sales Price by Type (2021-2026) & (US$/L) Table 148. Asia Inhaled Nitric Oxide Sales Price by Type (2027-2032) & (US$/L) Table 149. Asia Inhaled Nitric Oxide Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Inhaled Nitric Oxide Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 152. Asia Inhaled Nitric Oxide Sales by Application (2027-2032) & (M L) Table 153. Asia Inhaled Nitric Oxide Sales Price by Application (2021-2026) & (US$/L) Table 154. Asia Inhaled Nitric Oxide Sales Price by Application (2027-2032) & (US$/L) Table 155. Asia Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Inhaled Nitric Oxide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Inhaled Nitric Oxide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032) & (M L) Table 159. Asia Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 160. Asia Inhaled Nitric Oxide Sales by Country (2027-2032) & (M L) Table 161. Asia Inhaled Nitric Oxide Sales Price by Country (2021-2026) & (US$/L) Table 162. Asia Inhaled Nitric Oxide Sales Price by Country (2027-2032) & (US$/L) Table 163. Japan Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 164. South Korea Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 165. India Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 166. Australia Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 167. Taiwan Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Inhaled Nitric Oxide Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Inhaled Nitric Oxide Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Inhaled Nitric Oxide Sales by Type (2021-2026) & (M L) Table 172. SAMEA Inhaled Nitric Oxide Sales by Type (2027-2032) & (M L) Table 173. SAMEA Inhaled Nitric Oxide Sales Price by Type (2021-2026) & (US$/L) Table 174. SAMEA Inhaled Nitric Oxide Sales Price by Type (2027-2032) & (US$/L) Table 175. SAMEA Inhaled Nitric Oxide Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Inhaled Nitric Oxide Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Inhaled Nitric Oxide Sales by Application (2021-2026) & (M L) Table 178. SAMEA Inhaled Nitric Oxide Sales by Application (2027-2032) & (M L) Table 179. SAMEA Inhaled Nitric Oxide Sales Price by Application (2021-2026) & (US$/L) Table 180. SAMEA Inhaled Nitric Oxide Sales Price by Application (2027-2032) & (US$/L) Table 181. SAMEA Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Inhaled Nitric Oxide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Inhaled Nitric Oxide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032) & (M L) Table 185. SAMEA Inhaled Nitric Oxide Sales by Country (2021-2026) & (M L) Table 186. SAMEA Inhaled Nitric Oxide Sales by Country (2027-2032) & (M L) Table 187. SAMEA Inhaled Nitric Oxide Sales Price by Country (2021-2026) & (US$/L) Table 188. SAMEA Inhaled Nitric Oxide Sales Price by Country (2027-2032) & (US$/L) Table 189. Brazil Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 190. Argentina Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 191. Chile Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 192. Colombia Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 193. Peru Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 195. Israel Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 196. UAE Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 197. Turkey Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 198. Iran Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 199. Egypt Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Inhaled Nitric Oxide Distributors List Table 203. Inhaled Nitric Oxide Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Image Figure 2. Global Inhaled Nitric Oxide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Market Size Share 2021 VS 2025 VS 2032 Figure 4. 800 ppm Image Figure 5. 100 ppm Image Figure 6. Others Image Figure 7. Global Inhaled Nitric Oxide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Inhaled Nitric Oxide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Near-term and Pre-term Infants PPHN Image Figure 10. Children and Adult ARDS Image Figure 11. Other Diseases Image Figure 12. Global Inhaled Nitric Oxide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Inhaled Nitric Oxide Revenue (2021-2032) & (US$ Million) Figure 14. Global Inhaled Nitric Oxide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Inhaled Nitric Oxide Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Inhaled Nitric Oxide Revenue Market Share by Region (2021-2032) Figure 17. Global Inhaled Nitric Oxide Sales (2021-2032) & (M L) Figure 18. Global Inhaled Nitric Oxide Sales by Region: 2021 VS 2025 VS 2032 (M L) Figure 19. Global Inhaled Nitric Oxide Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Inhaled Nitric Oxide Sales YoY (2021-2032) & (M L) Figure 21. Europe Inhaled Nitric Oxide Sales YoY (2021-2032) & (M L) Figure 22. China Inhaled Nitric Oxide Sales YoY (2021-2032) & (M L) Figure 23. Asia (Excluding China) Inhaled Nitric Oxide Sales YoY (2021-2032) & (M L) Figure 24. South America, Middle East and Africa Inhaled Nitric Oxide Sales YoY (2021-2032) & (M L) Figure 25. Global Inhaled Nitric Oxide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Inhaled Nitric Oxide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Inhaled Nitric Oxide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Inhaled Nitric Oxide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Inhaled Nitric Oxide Revenue Market Share by Type (2021-2032) Figure 31. Global Inhaled Nitric Oxide Sales by Type (2021 VS 2025 VS 2032) & (M L) Figure 32. Global Inhaled Nitric Oxide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Inhaled Nitric Oxide Sales Market Share by Type (2021-2032) Figure 34. Global Inhaled Nitric Oxide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Inhaled Nitric Oxide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Inhaled Nitric Oxide Revenue Market Share by Application (2021-2032) Figure 37. Global Inhaled Nitric Oxide Sales by Application (2021 VS 2025 VS 2032) & (M L) Figure 38. Global Inhaled Nitric Oxide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Inhaled Nitric Oxide Sales Market Share by Application (2021-2032) Figure 40. North America Inhaled Nitric Oxide Revenue Share by Type (2021-2032) Figure 41. North America Inhaled Nitric Oxide Sales Share by Type (2021-2032) Figure 42. North America Inhaled Nitric Oxide Revenue Share by Application (2021-2032) Figure 43. North America Inhaled Nitric Oxide Sales Share by Application (2021-2032) Figure 44. North America Inhaled Nitric Oxide Revenue Share by Country (2021-2032) Figure 45. North America Inhaled Nitric Oxide Sales Share by Country (2021-2032) Figure 46. Europe Inhaled Nitric Oxide Revenue Share by Type (2021-2032) Figure 47. Europe Inhaled Nitric Oxide Sales Share by Type (2021-2032) Figure 48. Europe Inhaled Nitric Oxide Revenue Share by Application (2021-2032) Figure 49. Europe Inhaled Nitric Oxide Sales Share by Application (2021-2032) Figure 50. Europe Inhaled Nitric Oxide Revenue Share by Country (2021-2032) Figure 51. Europe Inhaled Nitric Oxide Sales Share by Country (2021-2032) Figure 52. China Inhaled Nitric Oxide Revenue Share by Type (2021-2032) Figure 53. China Inhaled Nitric Oxide Sales Share by Type (2021-2032) Figure 54. China Inhaled Nitric Oxide Revenue Share by Application (2021-2032) Figure 55. China Inhaled Nitric Oxide Sales Share by Application (2021-2032) Figure 56. Asia Inhaled Nitric Oxide Revenue Share by Type (2021-2032) Figure 57. Asia Inhaled Nitric Oxide Sales Share by Type (2021-2032) Figure 58. Asia Inhaled Nitric Oxide Revenue Share by Application (2021-2032) Figure 59. Asia Inhaled Nitric Oxide Sales Share by Application (2021-2032) Figure 60. Asia Inhaled Nitric Oxide Revenue Share by Country (2021-2032) Figure 61. Asia Inhaled Nitric Oxide Sales Share by Country (2021-2032) Figure 62. SAMEA Inhaled Nitric Oxide Revenue Share by Type (2021-2032) Figure 63. SAMEA Inhaled Nitric Oxide Sales Share by Type (2021-2032) Figure 64. SAMEA Inhaled Nitric Oxide Revenue Share by Application (2021-2032) Figure 65. SAMEA Inhaled Nitric Oxide Sales Share by Application (2021-2032) Figure 66. SAMEA Inhaled Nitric Oxide Revenue Share by Country (2021-2032) Figure 67. SAMEA Inhaled Nitric Oxide Sales Share by Country (2021-2032) Figure 68. Inhaled Nitric Oxide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Inhaled Nitric Oxide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 800 ppm
  • 100 ppm
  • Others
Applications
  • Near-term and Pre-term Infants PPHN
  • Children and Adult ARDS
  • Other Diseases
Companies covered
  • Mallinckrodt
  • Praxair (Linde plc)
  • Air Liquide
  • BOC Healthcare (Linde Group)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Inhaled Nitric Oxide Market by Type
  3. 1.2.1 Global Inhaled Nitric Oxide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 800 ppm
  5. 1.2.3 100 ppm
  6. 1.2.4 Others
  7. 1.3 Inhaled Nitric Oxide Market by Application
  8. 1.3.1 Global Inhaled Nitric Oxide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Near-term and Pre-term Infants PPHN
  10. 1.3.3 Children and Adult ARDS
  11. 1.3.4 Other Diseases
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Inhaled Nitric Oxide Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Industry Trends
  2. 2.2 Inhaled Nitric Oxide Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Inhaled Nitric Oxide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Inhaled Nitric Oxide Revenue by Region
  3. 3.2.1 Global Inhaled Nitric Oxide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Inhaled Nitric Oxide Revenue by Region (2021-2026)
  5. 3.2.3 Global Inhaled Nitric Oxide Revenue by Region (2027-2032)
  6. 3.2.4 Global Inhaled Nitric Oxide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Inhaled Nitric Oxide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Inhaled Nitric Oxide Sales by Region
  9. 3.4.1 Global Inhaled Nitric Oxide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Inhaled Nitric Oxide Sales by Region (2021-2026)
  11. 3.4.3 Global Inhaled Nitric Oxide Sales by Region (2027-2032)
  12. 3.4.4 Global Inhaled Nitric Oxide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Inhaled Nitric Oxide Revenue by Manufacturers
  2. 4.1.1 Global Inhaled Nitric Oxide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Inhaled Nitric Oxide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Inhaled Nitric Oxide Sales by Manufacturers
  6. 4.2.1 Global Inhaled Nitric Oxide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Inhaled Nitric Oxide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Inhaled Nitric Oxide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Inhaled Nitric Oxide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Inhaled Nitric Oxide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Inhaled Nitric Oxide Manufacturers, Product Type & Application
  13. 4.7 Global Inhaled Nitric Oxide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Inhaled Nitric Oxide Market CR5 and HHI
  16. 4.8.2 2025 Inhaled Nitric Oxide Tier 1, Tier 2, and Tier 3
5 Inhaled Nitric Oxide Market by Type
  1. 5.1 Global Inhaled Nitric Oxide Revenue by Type
  2. 5.1.1 Global Inhaled Nitric Oxide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Inhaled Nitric Oxide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Inhaled Nitric Oxide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Inhaled Nitric Oxide Sales by Type
  6. 5.2.1 Global Inhaled Nitric Oxide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhaled Nitric Oxide Sales by Type (2021-2032) & (M L)
  8. 5.2.3 Global Inhaled Nitric Oxide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Inhaled Nitric Oxide Price by Type
6 Inhaled Nitric Oxide Market by Application
  1. 6.1 Global Inhaled Nitric Oxide Revenue by Application
  2. 6.1.1 Global Inhaled Nitric Oxide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Inhaled Nitric Oxide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Inhaled Nitric Oxide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Inhaled Nitric Oxide Sales by Application
  6. 6.2.1 Global Inhaled Nitric Oxide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Inhaled Nitric Oxide Sales by Application (2021-2032) & (M L)
  8. 6.2.3 Global Inhaled Nitric Oxide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Inhaled Nitric Oxide Price by Application
7 Company Profiles
  1. 7.1 Mallinckrodt
  2. 7.1.1 Mallinckrodt Company Information
  3. 7.1.2 Mallinckrodt Business Overview
  4. 7.1.3 Mallinckrodt Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Mallinckrodt Inhaled Nitric Oxide Product Portfolio
  6. 7.1.5 Mallinckrodt Recent Developments
  7. 7.2 Praxair (Linde plc)
  8. 7.2.1 Praxair (Linde plc) Company Information
  9. 7.2.2 Praxair (Linde plc) Business Overview
  10. 7.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio
  12. 7.2.5 Praxair (Linde plc) Recent Developments
  13. 7.3 Air Liquide
  14. 7.3.1 Air Liquide Company Information
  15. 7.3.2 Air Liquide Business Overview
  16. 7.3.3 Air Liquide Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Air Liquide Inhaled Nitric Oxide Product Portfolio
  18. 7.3.5 Air Liquide Recent Developments
  19. 7.4 BOC Healthcare (Linde Group)
  20. 7.4.1 BOC Healthcare (Linde Group) Company Information
  21. 7.4.2 BOC Healthcare (Linde Group) Business Overview
  22. 7.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio
  24. 7.4.5 BOC Healthcare (Linde Group) Recent Developments
8 North America
  1. 8.1 North America Inhaled Nitric Oxide Market Size by Type
  2. 8.1.1 North America Inhaled Nitric Oxide Revenue by Type (2021-2032)
  3. 8.1.2 North America Inhaled Nitric Oxide Sales by Type (2021-2032)
  4. 8.1.3 North America Inhaled Nitric Oxide Price by Type (2021-2032)
  5. 8.2 North America Inhaled Nitric Oxide Market Size by Application
  6. 8.2.1 North America Inhaled Nitric Oxide Revenue by Application (2021-2032)
  7. 8.2.2 North America Inhaled Nitric Oxide Sales by Application (2021-2032)
  8. 8.2.3 North America Inhaled Nitric Oxide Price by Application (2021-2032)
  9. 8.3 North America Inhaled Nitric Oxide Market Size by Country
  10. 8.3.1 North America Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Inhaled Nitric Oxide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Inhaled Nitric Oxide Market Size by Type
  2. 9.1.1 Europe Inhaled Nitric Oxide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Inhaled Nitric Oxide Sales by Type (2021-2032)
  4. 9.1.3 Europe Inhaled Nitric Oxide Price by Type (2021-2032)
  5. 9.2 Europe Inhaled Nitric Oxide Market Size by Application
  6. 9.2.1 Europe Inhaled Nitric Oxide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Inhaled Nitric Oxide Sales by Application (2021-2032)
  8. 9.2.3 Europe Inhaled Nitric Oxide Price by Application (2021-2032)
  9. 9.3 Europe Inhaled Nitric Oxide Market Size by Country
  10. 9.3.1 Europe Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Inhaled Nitric Oxide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Inhaled Nitric Oxide Market Size by Type
  2. 10.1.1 China Inhaled Nitric Oxide Revenue by Type (2021-2032)
  3. 10.1.2 China Inhaled Nitric Oxide Sales by Type (2021-2032)
  4. 10.1.3 China Inhaled Nitric Oxide Price by Type (2021-2032)
  5. 10.2 China Inhaled Nitric Oxide Market Size by Application
  6. 10.2.1 China Inhaled Nitric Oxide Revenue by Application (2021-2032)
  7. 10.2.2 China Inhaled Nitric Oxide Sales by Application (2021-2032)
  8. 10.2.3 China Inhaled Nitric Oxide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Inhaled Nitric Oxide Market Size by Type
  2. 11.1.1 Asia Inhaled Nitric Oxide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Inhaled Nitric Oxide Sales by Type (2021-2032)
  4. 11.1.3 Asia Inhaled Nitric Oxide Price by Type (2021-2032)
  5. 11.2 Asia Inhaled Nitric Oxide Market Size by Application
  6. 11.2.1 Asia Inhaled Nitric Oxide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Inhaled Nitric Oxide Sales by Application (2021-2032)
  8. 11.2.3 Asia Inhaled Nitric Oxide Price by Application (2021-2032)
  9. 11.3 Asia Inhaled Nitric Oxide Market Size by Country
  10. 11.3.1 Asia Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Inhaled Nitric Oxide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Inhaled Nitric Oxide Market Size by Type
  2. 12.1.1 SAMEA Inhaled Nitric Oxide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Inhaled Nitric Oxide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Inhaled Nitric Oxide Price by Type (2021-2032)
  5. 12.2 SAMEA Inhaled Nitric Oxide Market Size by Application
  6. 12.2.1 SAMEA Inhaled Nitric Oxide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Inhaled Nitric Oxide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Inhaled Nitric Oxide Price by Application (2021-2032)
  9. 12.3 SAMEA Inhaled Nitric Oxide Market Size by Country
  10. 12.3.1 SAMEA Inhaled Nitric Oxide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Inhaled Nitric Oxide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Inhaled Nitric Oxide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Inhaled Nitric Oxide Value Chain Analysis
  2. 13.1.1 Inhaled Nitric Oxide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Inhaled Nitric Oxide Production Mode & Process
  6. 13.2 Inhaled Nitric Oxide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Inhaled Nitric Oxide Distributors
  9. 13.2.3 Inhaled Nitric Oxide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst